I reported previously (see here) on Israel’s MedyMatch and its Artificial Intelligent Accipio Ix intracranial hemorrhage detection software.  MedyMatch (renamed MaxQ AI) has now received both FDA and CE approval to sell its systems in both the US and in Europe.

https://www.prnewswire.com/news-releases/maxq-ai-receives-fda-clearance-for-accipio-ix-intracranial-hemorrhage-diagnostics-intelligence-platform-300745201.html

https://www.youtube.com/watch?v=9UrqJ84BJbc